The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Epigenetic mechanisms in diabetic complications and metabolic memory
Open accessAbstract
The incidence of diabetes and its associated micro- and macrovascular complications is greatly increasing worldwide. The most prevalent vascular complications of both type 1 and type 2 diabetes include nephropathy, retinopathy, neuropathy and cardiovascular diseases. Evidence suggests that both genetic and environmental factors are involved in these pathologies. Clinical trials have underscored the beneficial effects of intensive glycaemic control for preventing the progression of complications. Accumulating evidence suggests a key role for epigenetic mechanisms such as DNA methylation, histone post-translational modifications in chromatin, and non-coding RNAs in the complex interplay between genes and the environment. Factors associated with the pathology of diabetic complications, including hyperglycaemia, growth factors, oxidant stress and inflammatory factors can lead to dysregulation of these epigenetic mechanisms to alter the expression of pathological genes in target cells such as endothelial, vascular smooth muscle, retinal and cardiac cells, without changes in the underlying DNA sequence. Furthermore, long-term persistence of these alterations to the epigenome may be a key mechanism underlying the phenomenon of ‘metabolic memory’ and sustained vascular dysfunction despite attainment of glycaemic control. Current therapies for most diabetic complications have not been fully efficacious, and hence a study of epigenetic mechanisms that may be involved is clearly warranted as they can not only shed novel new insights into the pathology of diabetic complications, but also lead to the identification of much needed new drug targets. In this review, we highlight the emerging role of epigenetics and epigenomics in the vascular complications of diabetes and metabolic memory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
Guttman, M., Amit, I., Garber, M., French, C., Lin, M. F., Feldser, D., Huarte, M., Zuk, O., Carey, B. W., Cassady, J. P., et al. (2009) · Nature · doi:10.1038/nature07672 · Cited by 4,098
Genome Regulation by Long Noncoding RNAs
Rinn, J. L., & Chang, H. Y. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051410-092902 · Cited by 4,005
Systematic Localization of Common Disease-Associated Variation in Regulatory DNA
Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., et al. (2012) · Science · doi:10.1126/science.1222794 · Cited by 3,716 · cited 1×
“Furthermore, most disease-associated SNPs are present in non-coding or other regulatory regions of the genome such as enhancers [44], which can affect gene expression by altering transcription factor binding.”
Cabili, M. N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A., & Rinn, J. L. (2011) · Genes & Development · doi:10.1101/gad.17446611 · Cited by 3,502
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871 · cited 2×
“Because epigenetic changes are potentially reversible in nature, combination therapies with epigenetic drugs (epidrugs) [38] and antagomirs (miRNA inhibitors) [8] could be considered to complement the current treatments for complications.”
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Environmental epigenomics and disease susceptibility
Jirtle, R. L., & Skinner, M. K. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2045 · Cited by 2,492
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · cited 1×
“Overall, the crosstalk and interplay between histone PTMs, DNAme and ncRNAs provides another layer of epigenetic regulation to impact gene expression [62, 63], which, if dysregulated, can result in diabetes and associated complications.”
Modular regulatory principles of large non-coding RNAs
Guttman, M., & Rinn, J. L. (2012) · Nature · doi:10.1038/nature10887 · Cited by 2,265
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Principles and challenges of genome-wide DNA methylation analysis
Laird, P. W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2732 · Cited by 1,572
Charting histone modifications and the functional organization of mammalian genomes
Zhou, V. W., Goren, A., & Bernstein, B. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2905 · Cited by 1,147
El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115 · cited 4×
“In vascular endothelial cells, high glucose treatment increased the expression of the NF-κB active subunit (p65) and inflammatory genes by promoting SET7 recruitment and H3K4me1 enrichment at their promoters [26], while also directly promoting nuclear localisation and activity of SET7 [82].”
InfluentialActivation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 985
New nomenclature for chromatin-modifying enzymes
Allis, C. D., Berger, S. L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L., Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.039 · Cited by 957
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Regulation of histone methylation by demethylimination and demethylation
Klose, R. J., & Zhang, Y. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2143 · Cited by 887
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 775
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Methylation determines fibroblast activation and fibrogenesis in the kidney
Bechtel, W., McGoohan, S., Zeisberg, E. M., Müller, G. A., Kalbacher, H., Salant, D. J., Müller, C. A., Kalluri, R., & Zeisberg, M. (2010) · Nature Medicine · doi:10.1038/nm.2135 · Cited by 639
Epigenetics: a molecular link between environmental factors and type 2 diabetes
Ling, C., & Groop, L. (2009) · Diabetes · doi:10.2337/db09-1003 · Cited by 617
Next-generation genomics: an integrative approach
Hawkins, R. D., Hon, G. C., & Ren, B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2795 · Cited by 593
TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1897 · Cited by 573
Self-citationBrasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K., Calkin, A. C., Brownlee, M., Cooper, M. E., & El-Osta, A. (2009) · Diabetes · doi:10.2337/db08-1666 · Cited by 534
Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06320.x · Cited by 521
Progression of Incipient Diabetic Retinopathy During Good Glycemic Control
Engerman, R. L., & Kern, T. S. (1987) · Diabetes · doi:10.2337/diab.36.7.808 · Cited by 490
Hasegawa, K., Wakino, S., Simic, P., Sakamaki, Y., Minakuchi, H., Fujimura, K., Hosoya, K., Komatsu, M., Kaneko, Y., Kanda, T., et al. (2013) · Nature Medicine · doi:10.1038/nm.3363 · Cited by 483
An encyclopedia of mouse DNA elements (Mouse ENCODE)
Mouse ENCODE Consortium, Stamatoyannopoulos, J. A., Snyder, M., Hardison, R., Ren, B., Gingeras, T., Gilbert, D. M., Groudine, M., Bender, M., Kaul, R., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-8-418 · Cited by 446
Villeneuve, L. M., Reddy, M. A., Lanting, L. L., Wang, M., Meng, L., & Natarajan, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803623105 · Cited by 412
Self-citationDNA Methylation and Demethylation in Mammals
Chen, Z.-X., & Riggs, A. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.205286 · Cited by 395
Miao, F., Gonzalo, I. G., Lanting, L., & Natarajan, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311786200 · Cited by 374
Self-citationLi, Y., Reddy, M. A., Miao, F., Shanmugam, N., Yee, J.-K., Hawkins, D., Ren, B., & Natarajan, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802800200 · Cited by 353
Self-citationSimon, J. M., Giresi, P. G., Davis, I. J., & Lieb, J. D. (2012) · Nature Protocols · doi:10.1038/nprot.2011.444 · Cited by 329
The RAAS in the pathogenesis and treatment of diabetic nephropathy
Ruggenenti, P., Cravedi, P., & Remuzzi, G. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.58 · Cited by 319
Diabetic nephropathy—emerging epigenetic mechanisms
Kato, M., & Natarajan, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.116 · Cited by 318
Self-citationGenome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus
Bell, C. G., Teschendorff, A. E., Rakyan, V. K., Maxwell, A. P., Beck, S., & Savage, D. A. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-33 · Cited by 305
The role of epigenetics in the pathology of diabetic complications
Villeneuve, L. M., & Natarajan, R. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00200.2010 · Cited by 295
Self-citationDiabetes Complications: The MicroRNA Perspective
Kantharidis, P., Wang, B., Carew, R. M., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db11-0082 · Cited by 289
Kowluru, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.818 · Cited by 282
New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
Sandholm, N., Salem, R. M., McKnight, A. J., Brennan, E. P., Forsblom, C., Isakova, T., McKay, G. J., Williams, W. W., Sadlier, D. M., Mäkinen, V.-P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002921 · Cited by 278
Novel Long Noncoding RNAs Are Regulated by Angiotensin II in Vascular Smooth Muscle Cells
Leung, A., Trac, C., Jin, W., Lanting, L., Akbany, A., Sætrom, P., Schones, D. E., & Natarajan, R. (2013) · Circulation Research · doi:10.1161/circresaha.112.300849 · Cited by 268
Self-citationChalmers, J., & Cooper, M. E. (2008) · New England Journal of Medicine · doi:10.1056/nejme0807625 · Cited by 263 · cited 1×
“Other trials with type 2 diabetic patients have also found that the benefits of intensive glycaemic control lasted long after cessation of intervention, suggesting a ‘legacy effect’ [22].”
Nutrition, Epigenetics, and Metabolic Syndrome
Wang, J., Wu, Z., Li, D., Li, N., Dindot, S. V., Satterfield, M. C., Bazer, F. W., & Wu, G. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4381 · Cited by 261
Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
Miao, F., Chen, Z., Genuth, S., Paterson, A., Zhang, L., Wu, X., Li, S. M., Cleary, P., Riggs, A., Harlan, D. M., et al. (2014) · Diabetes · doi:10.2337/db13-1251 · Cited by 253
Self-citationMiao, F., Smith, D. D., Zhang, L., Min, A., Feng, W., & Natarajan, R. (2008) · Diabetes · doi:10.2337/db08-0645 · Cited by 247
Self-citationPerrone, L., Devi, T. S., Hosoya, K., Terasaki, T., & Singh, L. P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21852 · Cited by 243
Epigenetic Histone Methylation Modulates Fibrotic Gene Expression
Sun, G., Reddy, M. A., Yuan, H., Lanting, L., Kato, M., & Natarajan, R. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060633 · Cited by 238
Self-citationSmith, E., & Shilatifard, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.11.031 · Cited by 237
Fong, D. S., Aiello, L., Gardner, T. W., King, G. L., Blankenship, G., Cavallerano, J. D., Ferris, F. L., Klein, R., & American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.1.226 · Cited by 233
Lipid Inflammatory Mediators in Diabetic Vascular Disease
Natarajan, R., & Nadler, J. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000133606.69732.4c · Cited by 232
Self-citationKo, Y.-A., Mohtat, D., Suzuki, M., Park, A. S. D., Izquierdo, M. C., Han, S. Y., Kang, H. M., Si, H., Hostetter, T., Pullman, J. M., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r108 · Cited by 225 · cited 1×
“Of note, an examination of DNAme profiles in microdissected tubuli obtained from patients with CKD and diabetic nephropathy vs controls revealed significant differences in their genome-wide DNAme (methylomes), with key differentially methylated genes being related to fibrosis [52], indicating direct connections betwee…”
Pirola, L., Balcerczyk, A., Tothill, R. W., Haviv, I., Kaspi, A., Lunke, S., Ziemann, M., Karagiannis, T., Tonna, S., Kowalczyk, A., et al. (2011) · Genome Research · doi:10.1101/gr.116095.110 · Cited by 223
Zhong, Q., & Kowluru, R. A. (2011) · Diabetes · doi:10.2337/db10-0133 · Cited by 210
Sapienza, C., Lee, J., Powell, J., Erinle, O., Yafai, F., Reichert, J., Siraj, E. S., & Madaio, M. (2011) · Epigenetics · doi:10.4161/epi.6.1.13362 · Cited by 208
Epigenetic mechanisms in diabetic vascular complications
Reddy, M. A., & Natarajan, R. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr024 · Cited by 199
Self-citationVilleneuve, L. M., Kato, M., Reddy, M. A., Wang, M., Lanting, L., & Natarajan, R. (2010) · Diabetes · doi:10.2337/db10-0208 · Cited by 186
Self-citationMoving AHEAD with an international human epigenome project
The American Association for Cancer Research Human Epigenome Task Force, Jones, P. A., Archer, T. K., Baylin, S. B., Beck, S., Berger, S., Bernstein, B. E., Carpten, J. D., Clark, S. J., Costello, J. F., et al. (2008) · Nature · doi:10.1038/454711a · Cited by 186
Miao, F., Wu, X., Zhang, L., Yuan, Y.-C., Riggs, A. D., & Natarajan, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609446200 · Cited by 182
Self-citationDistinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells
Okabe, J., Orlowski, C., Balcerczyk, A., Tikellis, C., Thomas, M. C., Cooper, M. E., & El-Osta, A. (2012) · Circulation Research · doi:10.1161/circresaha.112.266171 · Cited by 180
Hodgin, J. B., Nair, V., Zhang, H., Randolph, A., Harris, R. C., Nelson, R. G., Weil, E. J., Cavalcoli, J. D., Patel, J. M., Brosius, F. C., et al. (2013) · Diabetes · doi:10.2337/db11-1667 · Cited by 178
Regulation of Inflammatory Phenotype in Macrophages by a Diabetes-Induced Long Noncoding RNA
Reddy, M. A., Chen, Z., Park, J. T., Wang, M., Lanting, L., Zhang, Q., Bhatt, K., Leung, A., Wu, X., Putta, S., et al. (2014) · Diabetes · doi:10.2337/db14-0298 · Cited by 171
Self-citationTranscription factors in the pathogenesis of diabetic nephropathy
Sanchez, A. P., & Sharma, K. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001057 · Cited by 167
Alvarez, M. L., & DiStefano, J. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018671 · Cited by 167
Yuan, H., Reddy, M. A., Sun, G., Lanting, L. L., Wang, M., Kato, M. V., & Natarajan, R. D. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00523.2012 · Cited by 150
Self-citationZhong, Q. P. W., & Kowluru, R. A. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10854 · Cited by 147
Bock, F. M., Shahzad, K., Wang, H., Stoyanov, S., Wolter, J., Dong, W., Pelicci, P. G., Kashif, M., Ranjan, S., Schmidt, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218667110 · Cited by 146
Zhong, Q. P. W., & Kowluru, R. A. (2013) · Diabetes · doi:10.2337/db12-1141 · Cited by 141
Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice
Reddy, M. A., Putta, S., Lanting, L. L., Yuan, H., Wang, M., Mar, D., Alpers, C. E., Bomsztyk, K., & Natarajan, R. D. (2013) · Kidney International · doi:10.1038/ki.2013.387 · Cited by 137
Self-citationMicroRNAs: potential mediators and biomarkers of diabetic complications
Kato, M. V., Castro, N., & Natarajan, R. D. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.009 · Cited by 134
Self-citationAcetylation of Retinal Histones in Diabetes Increases Inflammatory Proteins
Kadiyala, C. S. R., Zheng, L., Du, Y., Yohannes, E., Kao, H., Miyagi, M., & Kern, T. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.375204 · Cited by 129
Pro-Inflammatory Role of MicroRNA-200 in Vascular Smooth Muscle Cells From Diabetic Mice
Reddy, M. A., Jin, W. L., Villeneuve, L. M., Wang, M., Lanting, L. L., Todorov, I., Kato, M. V., & Natarajan, R. D. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241109 · Cited by 126
Self-citationRegulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
Feng, B., Chen, S., Chiu, J., George, B., & Chakrabarti, S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00029.2008 · Cited by 120
Li, S., Reddy, M. A., Cai, Q., Meng, L., Yuan, H., Lanting, L. L., & Natarajan, R. D. (2006) · Diabetes · doi:10.2337/db06-0164 · Cited by 120
Self-citationProfiles of Epigenetic Histone Post-translational Modifications at Type 1 Diabetes Susceptible Genes
Miao, F., Chen, Z., Zhang, L., Liu, Z., Wu, X., Yuan, Y., & Natarajan, R. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330373 · Cited by 114
Self-citationAlvarez, M. L., & DiStefano, J. K. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.010 · Cited by 114
Reversal of hyperglycemia and diabetic nephropathy
Kowluru, R. A., Abbas, S. N., & Odenbach, S. (2004) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.03.002 · Cited by 112
Epigenetics and maternal nutrition: nature v. nurture
Simmons, R. A. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110003988 · Cited by 112
Kaur, H., Chen, S., Xin, X., Chiu, J., Khan, Z. A., & Chakrabarti, S. K. (2006) · Diabetes · doi:10.2337/db06-0519 · Cited by 103
Chen, J., Guo, Y., Zeng, W., Huang, L., Pang, Q., Nie, L., Mu, J., Yuan, F., & Feng, B. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00697.2012 · Cited by 98
When Metabolism and Epigenetics Converge
Sassone‐Corsi, P. (2013) · Science · doi:10.1126/science.1233423 · Cited by 90
Open Chromatin Profiling in Mice Livers Reveals Unique Chromatin Variations Induced by High Fat Diet
Leung, A., Parks, B. W., Du, J., Trac, C., Setten, R. L., Chen, Y., Brown, K., Lusis, A. J., Natarajan, R. D., & Schones, D. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581439 · Cited by 88
Self-citationZiyadeh, F. N., & Sharma, K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065608.37756.58 · Cited by 87
Biology of diabetic neuropathy
Vincent, A. M., Calabek, B., Roberts, L., & Feldman, E. L. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00034-5 · Cited by 83
Genetic and epigenetic events in diabetic wound healing
Rafehi, H., El‐Osta, A., & Karagiannis, T. C. (2010) · International Wound Journal · doi:10.1111/j.1742-481x.2010.00745.x · Cited by 73
Das, F., Ghosh‐Choudhury, N., Venkatesan, B. A., Li, X., Mahimainathan, L., & Choudhury, G. G. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21236 · Cited by 61
MicroRNAs and their applications in kidney diseases
Badal, S. S., & Danesh, F. R. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2867-7 · Cited by 51
Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes
Komers, R., Mar, D., Denisenko, O. N., Xu, B., Oyama, T., & Bomsztyk, K. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.47 · Cited by 51
Glucose-Induced Metabolic Memory in Schwann Cells: Prevention by PPAR Agonists
Kim, E., Isoda, F., Kurland, I. J., & Mobbs, C. V. (2013) · Endocrinology · doi:10.1210/en.2013-1097 · Cited by 51
TCF7L2 Variation and Proliferative Diabetic Retinopathy
Luo, J., Zhao, L., Chen, A. Y., Zhang, X., Zhu, J., Zhao, J. J., Ouyang, H. W., Luo, H., Song, Y., Lee, J. S., et al. (2013) · Diabetes · doi:10.2337/db12-1093 · Cited by 44
Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes
Averill, M. M., & Bornfeldt, K. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0005-x · Cited by 39
Enhancers: Multi-dimensional signal integrators
Jin, F., Li, Y., Ren, B., & Natarajan, R. D. (2011) · Transcription · doi:10.4161/trns.2.5.17712 · Cited by 38
Self-citationEffect of Exercise on DNA Methylation and Metabolism in Human Adipose Tissue and Skeletal Muscle
Rönn, T., & Ling, C. (2013) · Epigenomics · doi:10.2217/epi.13.61 · Cited by 38
Genetic and Epigenetic Risk Factors for Diabetic Kidney Disease
McKnight, A. J., McKay, G. J., & Maxwell, A. P. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.010 · Cited by 32
MicroRNAs in diabetic cardiomyopathy and clinical perspectives
Zhou, Q., Lv, D., Chen, P., Xu, T., Fu, S., Li, J., & Bei, Y. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00185 · Cited by 29
Endothelial Transcriptome in Response to Pharmacological Methyltransferase Inhibition
Okabe, J., Fernández, A. Z., Ziemann, M., Keating, S. T., Balcerczyk, A., & El‐Osta, A. (2014) · ChemMedChem · doi:10.1002/cmdc.201402091 · Cited by 12
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“These structural changes may cause endothelial dysfunction and then atherosclerosis [98].”
BackgroundAhlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017) · JCI Insight · doi:10.1172/jci.insight.93751 · Cited by 1,057
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 879
Metadata
- Authors
- Reddy, M. A., Zhang, E., & Natarajan, R.
- Venue
- Diabetologia
- Published
- 2014-12-07
- Volume
- 58
- Issue
- 3
- Pages
- 443-455
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2044003590
- Cited by
- 496
- References
- 106
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.